Extended release oral Pharmaceutical Formulation in the form of multiparticulas, comprising 40) - or - (2-hydroxy ethyl) - Rapamycin and (b) at least one prolonged Release Coating.
The invention relates to extended release pharmaceutical formulations in form of multiparticulates comprising 40-O-(2-hydroxy)ethyl-rapamycin, to dosage forms which comprise said pharmaceutical formulations, to methods of preparing said pharmaceutical formulations and said dosage forms, to uses of said pharmaceutical formulations and said dosage for the manufacture of a medicament for the treatment or prevention of diseases or conditions responsive to inhibition of mTOR signaling pathway, such as for instance proliferative diseases or immunosuppression.FORMULACION FARMACEUTICA ORAL DE LIBERACION PROLONGADA EN FORMA DE MULTIPARTICULAS, QUE COMPRENDE (A) 40-O-(2-HIDROXI)ETIL-RAPAMICINA (EVEROLIMUS) Y (B) UNA CAPA DE RECUBRIMIENTO QUE COMPRENDE (I) UN POLÍMERO INSOLUBLE EN AGUA, Y (II) UNA CAPA PROTECTORA； FORMA DE DOSIFICACION ORAL； PROCESO DE PREPARACION； Y USO.
